Last reviewed · How we verify
NCT04749992: BFD
Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction
trial testing Polysomnographic examination in sleep laboratory (PSG measurement) in Dream Disorder in 142 participants. Terminated before completion.
8 March 2024
Quick facts
| Lead sponsor | International Psychoanalytic University Berlin |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 142 |
| Start date | 1 August 2018 |
| Primary completion | 8 March 2024 |
| Estimated completion | 8 March 2024 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- Polysomnographic examination in sleep laboratory (PSG measurement)
Conditions studied
- Dream Disorder — all drugs for Dream Disorder →
- Thrombotic Infarction — all drugs for Thrombotic Infarction →
- PCA Infarct — all drugs for PCA Infarct →
Sponsor
International Psychoanalytic University Berlin
Who can join
Adults 18 to 90, any sex, with Dream Disorder or Thrombotic Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a quasi-experimental between-group design. Using a prospective two-arm controlled exploratory study, data will be collected on an initial assessment of the effects of a specific neurological sample after thrombotic infarction (PCA infarction) who lost the ability to dream due to the infarction (experimental group) compared to a specific neurological sample after thrombotic infarction (PCA infarction) without loss of the ability to dream (comparison group) in terms of subjective and objective sleep quality and memory consolidation. Besides the importance to further elucidate the role of dreaming for sleep architecture and memory consolidation, the results of the evaluation are of great clinical relevance in a further scientific investigation regarding the treatment of a specifically neurological sample with acute thrombotic infarction.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research.
Koslowski M, de Haas MP, Fischmann T. · · 2023 · cited 8× · PMID 36875230 · DOI 10.3389/fnhum.2023.1080177 -
Exploring the biological function of dreaming: lessons learned from recruitment challenges in a pilot study with PCA stroke patients.
Fischmann T, Peters L, Rieker V, Koslowski M. · · 2025 · PMID 41425211 · DOI 10.3389/frsle.2025.1585263
Verify or expand the search:
- PubMed search for NCT04749992
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04749992 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by International Psychoanalytic University Berlin
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749992.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing